Guillermo de Anda-Jáuregui

Orcid: 0000-0002-7749-0365

According to our database1, Guillermo de Anda-Jáuregui authored at least 15 papers between 2015 and 2024.

Collaborative distances:
  • Dijkstra number2 of five.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

On csauthors.net:

Bibliography

2024
The ROSMAP project: aging and neurodegenerative diseases through omic sciences.
Frontiers Neuroinformatics, 2024

2023
Drug repurposing for Basal breast cancer subpopulations using modular network signatures.
Comput. Biol. Chem., August, 2023

2022
Intermunicipal Travel Networks of Mexico (2020-2021).
CoRR, 2022

Distinguishing In-Groups and Onlookers by Language Use.
Proceedings of the 12th Workshop on Computational Approaches to Subjectivity, 2022

2021
When the Echo Chamber Shatters: Examining the Use of Community-Specific Language Post-Subreddit Ban.
CoRR, 2021

2020
The Contact Network of Mexico City.
CoRR, 2020

2019
Spatial Organization of the Gene Regulatory Program: An Information Theoretical Approach to Breast Cancer Transcriptomics.
Entropy, 2019

A Boolean Network Approach to Estrogen Transcriptional Regulation.
Complex., 2019

Identification of Casiopeina II-gly secondary targets through a systems pharmacology approach.
Comput. Biol. Chem., 2019

Correction to: Pathway crosstalk perturbation network modeling for identification of connectivity changes induced by diabetic neuropathy and pioglitazone.
BMC Syst. Biol., 2019

Pathway crosstalk perturbation network modeling for identification of connectivity changes induced by diabetic neuropathy and pioglitazone.
BMC Syst. Biol., 2019

Functional and transcriptional connectivity of communities in breast cancer co-expression networks.
Appl. Netw. Sci., 2019

Guideline for comparing functional enrichment of biological network modular structures.
Appl. Netw. Sci., 2019

2018
Probabilistic Multilayer Networks.
CoRR, 2018

2015
Crosstalk events in the estrogen signaling pathway may affect tamoxifen efficacy in breast cancer molecular subtypes.
Comput. Biol. Chem., 2015


  Loading...